Page last updated: 2024-09-03

astragaloside a and Acute Kidney Injury

astragaloside a has been researched along with Acute Kidney Injury in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Tang, JL; Xin, M; Zhang, LC1
Chen, D; Feng, M; Guo, H; Lv, J; Su, L; Tu, Y; Wang, Z; Zhang, C1
Gao, H; Gong, J; Hu, T; Li, Z; Qu, X; Song, Y; Sun, J; Tao, L; Zhai, J; Zhang, Y1
Chen, Y; Zhang, X; Zhou, W1
Chai, XQ; He, KQ; Jiang, Y; Li, WP; Li, WZ; Yin, YY1
Gui, D; Guo, Y; Huang, J; Liu, W; Wang, N; Xiao, W1

Other Studies

6 other study(ies) available for astragaloside a and Acute Kidney Injury

ArticleYear
Protective effect of Astragalus membranaceus and Astragaloside IV in sepsis-induced acute kidney injury.
    Aging, 2022, Jul-20, Volume: 14, Issue:14

    Topics: Acute Kidney Injury; Astragalus propinquus; Humans; Lipopolysaccharides; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Saponins; Sepsis; Triterpenes

2022
Astragaloside IV Protects Sepsis-induced Acute Kidney Injury by Attenuating Mitochondrial Dysfunction and Apoptosis in Renal Tubular Epithelial Cells.
    Current pharmaceutical design, 2022, Volume: 28, Issue:34

    Topics: Acute Kidney Injury; Animals; Apoptosis; Electron Transport Complex I; Epithelial Cells; Mice; Mitochondria; Saponins; Sepsis

2022
Altered metabolic profiles and biomarkers associated with astragaloside IV-mediated protection against cisplatin-induced acute kidney injury in rats: An HPLC-TOF/MS-based untargeted metabolomics study.
    Biochemical pharmacology, 2021, Volume: 183

    Topics: Acute Kidney Injury; Animals; Antineoplastic Agents; Biomarkers; Chromatography, High Pressure Liquid; Cisplatin; Male; Mass Spectrometry; Metabolome; Metabolomics; Rats; Rats, Sprague-Dawley; Saponins; Triterpenes

2021
Astragaloside IV Alleviates Lipopolysaccharide-Induced Acute Kidney Injury Through Down-Regulating Cytokines, CCR5 and p-ERK, and Elevating Anti-Oxidative Ability.
    Medical science monitor : international medical journal of experimental and clinical research, 2017, Mar-22, Volume: 23

    Topics: Acute Kidney Injury; Animals; Cytokines; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Interleukin-6; Kidney; Lipopolysaccharides; Male; Mice; Models, Animal; Reactive Oxygen Species; Receptors, CCR5; Saponins; Triterpenes; Tumor Necrosis Factor-alpha

2017
Astragaloside IV prevents kidney injury caused by iatrogenic hyperinsulinemia in a streptozotocin‑induced diabetic rat model.
    International journal of molecular medicine, 2018, Volume: 41, Issue:2

    Topics: Acute Kidney Injury; Animals; Antioxidants; Collagen Type IV; Diabetes Mellitus, Experimental; Glutathione Peroxidase; Humans; Hyperinsulinism; Iatrogenic Disease; Oxidative Stress; Podocytes; Rats; Rats, Sprague-Dawley; Saponins; Triterpenes

2018
Astragaloside IV prevents acute kidney injury in two rodent models by inhibiting oxidative stress and apoptosis pathways.
    Apoptosis : an international journal on programmed cell death, 2013, Volume: 18, Issue:4

    Topics: Acute Kidney Injury; Acute-Phase Proteins; Animals; Apoptosis; Caspase 3; Cell Adhesion Molecules; Cystatin C; Drugs, Chinese Herbal; Ischemia; Kidney; Kidney Function Tests; Lipocalin-2; Lipocalins; Male; Models, Animal; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Renal Artery; Reperfusion Injury; RNA, Messenger; Saponins; Triterpenes

2013